The peptide landscape is evolving faster than ever before — and 2026 may prove to be the biggest turning point yet. In this episode, Dr. Mike Belkowski breaks down the most important developments shaping the future of peptide science, longevity, metabolism, and mitochondrial medicine. From major FDA regulatory changes and groundbreaking clinical trials to the next generation of GLP-1 drugs, mitochondrial peptides, amylin agonists, oral peptide therapeutics, and the latest pharmaceutical breakthroughs, this episode explores where peptide medicine is headed over the next several years. You'll also hear why MOTS-c may be transitioning from a "biohacker peptide" into legitimate clinical medicine, why SS-31 represents a milestone for mitochondrial therapeutics, why retatrutide continues to redefine metabolic medicine, and which peptide trends deserve your attention moving forward. If you're interested in longevity, mitochondrial health, bioenergetics, metabolic optimization, or simply want to stay ahead of one of the fastest-moving fields in medicine, this episode is your comprehensive update. (Educational content only, not medical advice.) - Key Quotes From Dr. Mike: "The committee wasn't voting on whether these peptides work. They were voting on whether licensed compounding pharmacies should be allowed to prepare them." "Retatrutide is rapidly evolving from a weight-loss drug into a multi-system metabolic therapeutic." "Mitochondrial-targeted peptide therapy is becoming a legitimate therapeutic category." "MOTS-c is becoming one of the first true biohacker peptides to enter legitimate pharmaceutical research." "SS-31 is no longer theoretical — mitochondrial peptide therapy is now a clinical reality." "Intranasal mitochondrial peptides may have enormous future potential for brain health." "Amylin may become wave three of metabolic medicine." "Developers are now targeting energy expenditure, liver metabolism, adipose biology, and insulin signaling simultaneously." "Oral peptide therapeutics may become one of the biggest pharmaceutical revolutions of the next decade." "Peptides are one of the most exciting frontiers in health, longevity, and human energy." - Key Points ⚡ 2026 is becoming a landmark year for peptide science, regulation, and clinical development. ⚡ Four new BioLight Labs intranasal peptides were announced: MOTS-c, MOTS-c + SS-31, Oxytocin, and BPC-157. ⚡ The FDA's Pharmacy Compounding Advisory Committee recommended six peptides for potential future 503A compounding inclusion while rejecting DSIP. ⚡ Those FDA recommendations are advisory—not approvals—and formal rulemaking is still required. ⚡ Retatrutide continues to produce unprecedented weight-loss results approaching bariatric surgery outcomes. ⚡ GLP-1 therapies are evolving beyond weight loss into treatments for metabolic disease, sleep apnea, osteoarthritis, and other chronic conditions. ⚡ Amylin peptides are emerging as the next major frontier in obesity and metabolic medicine. ⚡ Petrelintide demonstrated impressive weight loss with placebo-like gastrointestinal tolerability. ⚡ Novo Nordisk's dual GLP-1/amylin peptide is advancing rapidly through clinical development. ⚡ MOTS-c has entered a randomized Phase 2 clinical trial, representing a major milestone for mitochondrial peptides. ⚡ MOTS-c is becoming one of the first "biohacker peptides" to transition into rigorous pharmaceutical research. ⚡ SS-31 (Elamipretide) became an FDA-approved mitochondrial-targeted peptide therapy for Barth syndrome. ⚡ Mitochondrial peptides are rapidly evolving from experimental longevity compounds into legitimate therapeutic candidates. ⚡ Dr. David Perlmutter's new book highlights mitochondrial health as a critical determinant of microglial function and brain health. ⚡ Intranasal mitochondrial peptides may eventually become promising tools for brain injury, stroke recovery, and neurodegeneration. ⚡ Servodutide is showing remarkable promise for fatty liver disease and obesity. ⚡ Pemvidutide produced encouraging Phase 2 results for alcohol use disorder. ⚡ Oral macrocyclic peptides are transforming peptide drug development by eliminating the need for injections. ⚡ Regulatory momentum around peptides continues to accelerate faster than human clinical evidence. ⚡ The peptide field is splitting into two worlds: highly engineered pharmaceutical drugs and early-stage regenerative peptides. ⚡ Curiosity should always be balanced with scientific evidence, safety, and quality. - Episode timeline 00:00 — Introduction & New BioLight Labs Intranasal Peptides 04:14 — FDA Peptide Regulatory Update 07:01 — Retatrutide Continues to Impress 08:44 — Amylin: The Next Metabolic Frontier 11:39 — MOTS-c Enters Phase 2 Clinical Trials 12:55 — Humanin, SHLPs & SS-31 14:47 — Brain Health, Microglia & Dr. David Perlmutter 18:48 — Servodutide & Fatty Liver Disease 19:55 — Pemvidutide & Addiction Research 21:35 — The Rise of Oral Peptides 22:57 — BPC-157, TB-500 & KPV: Regulatory Momentum vs Clinical Evidence 24:16 — FDA Preparing for the Generic GLP-1 Era 25:47 — Eight Peptide Trends to Watch 30:38 — Final Takeaways & The Future of Peptide Medicine - BioLight Labs Research Use Only Peptides Both injectables & nasal spray solutions High purity. High sterility. Low endotoxin. Verified through rigorous quality testing. Explore Peptides → BioLight Labs - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn BioLight Labs: Website Instagram BioLight: Website Instagram YouTube Facebook
In this special episode of The Energy Code, Dr. Mike Belkowski sits down with Jarrod Barakett, President of The Light System, to explore the intersection of light frequencies, bioenergetics, cellular energy, and human performance. Jarrod shares his deeply personal journey into frequency medicine, including how a severe spinal injury and emergency surgery led him to discover The Light System and the technology he credits with dramatically accelerating his recovery. Together, they explore the history and concepts behind The Light System, a technology originally developed by inventor Robert J. that uses coded affirmations, sacred geometry, and polychromatic light frequencies. Jarrod explains the system’s theories around cellular water, electrical voltage, energy flow, and the body’s ability to recover and adapt. The conversation covers everything from bio-photonic collisions and water restructuring to EMF-mitigating technology, quantum-charged vessels, cellular voltage, mindset, and the potential relationship between energy flow and human resilience. Educational content only. This episode is not medical advice. 🔥 In This Episode • Jarrod Barakett’s journey into frequency medicine and his recovery from a severe spinal injury • The history and origins of The Light System • Sacred geometry and its role in frequency-based technologies • How water may interact with frequency, words, and intention • Polychromatic light and bio-photonic collisions • Cellular electrical charge and the concept of “cellular voltage” • Environmental stressors including Bluetooth, Wi-Fi, and processed foods • Buccal cell testing and measurements of electrical conductivity • Quantum-charged water bottles, jewelry, and other products • The Light System’s approach to EMF exposure • Mental clarity, emotional resilience, grief, and energy flow • The placebo effect and the connection between mindset and physiology • Sunlight, frequency, peptides, and the future of medicine 💡 Key Takeaways • Jarrod’s personal recovery experience was a major catalyst for his interest in frequency medicine. • The Light System was developed around the concept of delivering coded affirmations through specific light frequencies. • The technology incorporates concepts including sacred geometry, polychromatic light, and frequency-based interactions with water. • Jarrod discusses the theory that restructuring cellular water may influence energy flow throughout the body. • Hybrid Light System units use opposing monitors to create what Jarrod describes as bio-photonic collisions and an associated energy field. • The conversation explores the idea that modern environmental factors may affect the body’s electrical charge and energy balance. • Jarrod discusses testing involving buccal cells that he says demonstrated measurable changes in cellular electrical conductivity. • Quantum-imprinted copper vessels are discussed as a way of transferring energy to drinking water. • The Light System smartwatch incorporates a quantum-charged stainless-steel band and coded affirmations. • The episode explores the relationship between mindset, intention, the placebo effect, and physiological responses. 🎙️ Key Quotes from Jarrod Barakett “Everything around us is made up of frequency… those frequencies exist, whether heard or not heard.” “By restructuring the water within our bodies, we are restructuring the energy flow within our body.” “When those photons leave each opposing monitor, they collide right in the center… and that collision creates a burst of energy.” “Instead of replenishing our energy tank through food… we need to expel more energy to get toxins out.” “If we can free up those blockages or make the flow of energy more efficient… then our body will be in a better place.” “We are giving the body more tools… elevating the electrical charge so the body is in a better place to do what it knows how to do.” “The mind is that powerful that if it truly believes something, then your body will follow.” ⏱️ Episode Timeline 00:00:00 — Introduction to The Energy Code & Jarrod Barakett 00:01:56 — Jarrod’s Background: Mindset, Agronomy & Cannabis Industry 00:03:46 — Severe Spinal Injury & Rapid 10-Week Recovery 00:07:50 — History & Origins of The Light System 00:10:39 — Mindset, Business Leadership & Energetic Principles 00:11:08 — Mid-Roll: Methylene Blue & Bio Blue Promotion 00:14:56 — Sacred Geometry, Spheres & Cubes 00:16:30 — Cellular Water, Frequency & Words 00:20:06 — Restructuring Energy Flow & Cellular Blockages 00:23:12 — Polychromatic Therapy & Bio-Photonic Collisions 00:26:06 — Cellular Voltage & Modern Environmental Toxins 00:30:49 — Jarrod’s Unconventional Recovery & Surgeon’s Reaction 00:34:31 — Buccal Cell Electrical Conductivity Research 00:36:03 — Quantum-Charged Water Bottles & Jewelry 00:37:39 — EMF Protection & The Quantum Smartwatch 00:43:11 — Testimonials & Real-World Experiences 00:44:36 — Product Breakdown: Pyramid Mini, Cubes & Dual-Cube Setups 00:47:08 — Product Placement: Garages, Bedrooms & Sleep 00:48:57 — Fibonacci Geometry, Cellular Voltage & Mitochondria 00:50:38 — Cleanses, Fasting & Glutathione 00:53:11 — Mental Health, Personal Tragedy & Resilience 00:56:58 — The Placebo Effect & Mind-Body Healing 00:58:57 — Rapid Fire: Sunlight, Frequency & Future Technologies 01:06:00 — Peptide Research: Follistatin, Klotho & Future Medicine 01:11:58 — Where to Find The Light System & Closing Remarks Follow & Learn More From Jarrod Barakett Jarrod Barakett Instagram (@jarrod.barakett)The Light System WebsiteThe Light System Instagram (@thelight.system)Books / Concepts / Researchers Mentioned Robert Religa (inventor of The Light System)Dr. Masaru Emoto (water and intention research)Fibonacci SequenceSacred Geometry - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn BioLight Labs: Website Instagram BioLight: Website Instagram YouTube Facebook
In this special Research Jamboree episode of The Energy Code, Dr. Mike Belkowski takes listeners on a rapid-fire tour through some of the most exciting mitochondrial research published over the past few months. Rather than diving deeply into one paper, this episode highlights ten cutting-edge studies spanning environmental toxins, mitochondrial peptides, gut health, Alzheimer's disease, osteoporosis, cardiovascular health, sex differences in metabolism, and one of the most fascinating breakthroughs yet — transplanting a person's own mitochondria into their eyes in an attempt to restore vision. Along the way, Dr. Mike explains what each study found, why it matters, where the science is headed, and what these discoveries reveal about the central role mitochondria play in virtually every aspect of human health. From glyphosate toxicity to Humanin, MOTS-c, Urolithin A, mitophagy, and the future of mitochondrial transplantation, this episode is packed with practical insights and exciting developments from the forefront of mitochondrial medicine. (Educational content only, not medical advice.) - Articles Discussed in Episode: Effects of Glyphosate and Roundup® Herbicides on Cardiac and H9c2 Cells' Mitochondrial Respiration and Oxidative Stress Sex Differences in Mitochondrial Function: Endocrine Regulation, Immunometabolic Signaling, and Implications for Health and Disease Targeting Mitochondrial Dysfunction to Quell Neuroinflammation in the Central Nervous System: A New Strategy for Treating Central Nervous System Disease with Nanomedicines Cholesterol in Mitochondrial Diseases: Friend or Foe? Mitigating Mitochondrial Dysfunction: A Novel Strategy for Chinese Botanical Drugs Against Osteoporosis Humanin and MOTS-c Attenuate Atrial Fibrillation by Suppressing Fibrosis and Mitochondrial Dysfunction The Gut Microbiome and Mitochondrial Function in Metabolism, Immunity, and Disease Urolithin A Activates Mitophagy via the AMPK-mTOR Axis and Modulates the Gut-Ceramide Axis to Ameliorate Cardiac Remodeling in HFpEF Mitophagy Deficiency and Calcium Dyshomeostasis Underlie the Pathogenesis and Progression of Alzheimer's Disease Patient's Own Mitochondria Injected Into Eyes in Attempt to Restore Vision - Key Quotes From Dr. Mike: "Roundup appears far more damaging to cardiac mitochondria than glyphosate by itself." "Mitochondria are essential signaling hubs linking endocrine health, immune function, and metabolism." "Mitochondrial dysfunction may be one of the primary drivers of neuroinflammation." "Cholesterol may actually be acting as a compensatory response to mitochondrial stress." "Lower Humanin and MOTS-c levels correlated with more severe atrial fibrosis." "Mitophagy continues to emerge as one of the most important longevity pathways." "Alzheimer's disease may be fueled by both mitophagy failure and calcium dysregulation." "Scientists have now injected a patient's own mitochondria into the eye." "Virtually every paper we discussed comes back to improving bioenergetics." - Key Points ⚡ This episode features a rapid-fire review of ten newly published mitochondrial research papers across multiple areas of health. ⚡ Commercial Roundup appears substantially more toxic to cardiac mitochondria than glyphosate alone, highlighting the importance of herbicide co-formulants. ⚡ Mitochondrial function differs significantly between men and women due to hormonal regulation throughout life. ⚡ Mitochondrial dysfunction may be a central driver of neuroinflammation and numerous neurological diseases. ⚡ Cholesterol may play a far more complex role in mitochondrial disease than previously appreciated. ⚡ Chinese botanical medicines may support osteoporosis by improving mitochondrial biogenesis, dynamics, and mitophagy. ⚡ Humanin and MOTS-c demonstrated promising effects in reducing atrial fibrosis and atrial fibrillation in preclinical research. ⚡ The gut microbiome may influence health primarily through its effects on mitochondrial resilience rather than microbial composition alone. ⚡ Urolithin A continues to demonstrate impressive mitophagy-promoting effects while improving heart function in heart failure models. ⚡ Alzheimer's disease progression appears closely linked to impaired mitophagy and disrupted calcium homeostasis. ⚡ Researchers successfully transplanted a patient's own mitochondria into the eye, demonstrating safety and temporary physiological improvements. ⚡ Mitochondrial transplantation could become one of the next major frontiers in regenerative medicine. ⚡ Throughout nearly every study, improved mitochondrial quality control, energy production, and bioenergetics emerged as common therapeutic themes. - Episode timeline Introduction: Research Jamboree Format BioLight Instagram Update & Free Speech Discussion Roundup vs. Glyphosate and Cardiac Mitochondria Sex Differences in Mitochondrial Function Mitochondria and Neuroinflammation Cholesterol's Role in Mitochondrial Disease Chinese Botanical Medicines & Osteoporosis Humanin + MOTS-c for Atrial Fibrillation Gut Microbiome & Mitochondrial Resilience Urolithin A for Heart Failure Mitophagy & Alzheimer's Disease Mitochondrial Transplantation to Restore Vision Final Thoughts & Future of Mitochondrial Medicine - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn BioLight Labs: Website Instagram BioLight: Website Instagram YouTube Facebook
Intranasal peptides have become one of the most exciting frontiers in peptide research — but which ones actually make sense, and why? In this episode, Dr. Mike Belkowski breaks down the science behind 14 different intranasal peptide formulations, explaining how the nasal cavity may provide a unique pathway to the brain through the olfactory and trigeminal nerves while partially bypassing the blood-brain barrier. From cognitive enhancement and stress resilience to mitochondrial function, neuroprotection, sleep, circadian biology, traumatic brain injury, neuroinflammation, and healthy brain aging, this episode explores the proposed mechanisms and emerging research behind today's most talked-about intranasal peptides. Dr. Mike reviews the evidence behind Semax, Selank, SS-31, MOTS-c, Humanin, Epitalon, Pinealon, BPC-157, KPV, DSIP, Oxytocin, and three novel peptide blends while emphasizing where the science is strongest — and where it's still highly theoretical. Whether you're interested in brain health, mitochondrial medicine, longevity, or peptide science, this episode serves as one of the most comprehensive overviews available on intranasal peptide research. (Educational content only, not medical advice.) - Key Quotes From Dr. Mike: "The nasal cavity provides one of the most unique access points we have to the central nervous system." "Intranasal delivery isn't magic — but for the right peptide, it may dramatically change where that peptide goes." "Semax is the accelerator, Selank is the stabilizer... One improves focus, the other improves calm." "Humanin may be one of the most exciting mitochondrial-derived peptides for brain recovery." "BPC-157 may be far more interesting for brain injury than most people realize." "KPV isn't just an anti-inflammatory peptide — it may become a neuroinflammatory peptide." "Oxytocin isn't simply the 'love hormone' — it's deeply involved in stress circuitry." "Brain health is ultimately an energy problem before it becomes a disease problem." - Key Points ⚡ Intranasal peptide delivery may provide direct access to the central nervous system through the olfactory and trigeminal pathways while partially bypassing the blood-brain barrier. ⚡ Unlike oral peptides, intranasal delivery avoids gastrointestinal degradation and first-pass liver metabolism. ⚡ Not every peptide is suitable for intranasal delivery — molecular size, stability, formulation, and nasal absorption all influence effectiveness. ⚡ Semax remains one of the most extensively studied intranasal peptides for cognition, neuroplasticity, and neuroprotection. ⚡ Selank is primarily researched for anxiety reduction, stress resilience, calm focus, and GABA-related signaling. ⚡ Combining Semax and Selank may provide complementary support for focus, learning, emotional regulation, and stress resilience. ⚡ SS-31 targets cardiolipin within mitochondria, making it one of the most unique mitochondrial peptides for neuronal energy production. ⚡ MOTS-c supports metabolic adaptation, mitochondrial resilience, and recovery following neurological stress. ⚡ An SS-31 + MOTS-c blend may offer one of the strongest theoretical approaches for mitochondrial brain support. ⚡ Humanin restores mitochondrial bioenergetics and synaptic function following traumatic brain injury in preclinical research. ⚡ Epitalon primarily targets circadian biology, pineal signaling, and healthy aging rather than acute cognitive enhancement. ⚡ Pinealon focuses more directly on cognition, neuroprotection, and neuronal resilience. ⚡ Combining Epitalon with Pinealon creates a longevity-focused formulation targeting both circadian biology and cognitive aging. ⚡ BPC-157 may have intriguing applications for traumatic brain injury, vascular integrity, and neuronal recovery. ⚡ KPV appears particularly promising for neuroinflammation and microglial regulation. ⚡ DSIP centers around restorative sleep, stress recovery, hypoxia tolerance, and mitochondrial support. ⚡ Oxytocin has one of the largest bodies of intranasal research for stress regulation, PTSD, emotional processing, and social cognition. ⚡ Many of these proposed applications remain mechanistic or preclinical and require substantially more human clinical research. ⚡ Rather than targeting neurotransmitters alone, many of these peptides aim to improve mitochondrial function, cellular resilience, inflammation, and recovery. ⚡ The episode concludes with a practical framework that categorizes every peptide by its primary research focus — from repair and inflammation to focus, calm, mitochondrial resilience, and longevity. - Episode timeline 00:00 — Introduction: Why Intranasal Peptides? 04:30 — How Nose-to-Brain Delivery Works 07:15 — Semax 11:12 — Selank 15:00 — Semax + Selank 17:10 — SS-31 22:40 — MOTS-c 26:40 — SS-31 + MOTS-c 28:24 — Humanin 31:50 — Epitalon 35:08 — Pinealon 37:25 — Epitalon + Pinealon 39:18 — BPC-157 45:52 — KPV 48:28 — DSIP 53:27 — Oxytocin 57:06 — Final Review & Best Use Cases - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn BioLight Labs: Website Instagram BioLight: Website Instagram YouTube Facebook
Could metabolic aging, chronic anxiety, and depression all share the same biological root? In this episode of The Energy Code, Dr. Mike Belkowski reviews three newly published studies that, when viewed together, point toward an emerging concept he calls the mitochondria-metabolism-brain axis. The first paper explores how GLP-1 medications may influence mitochondrial biology beyond weight loss by interacting with pathways involved in mitochondrial biogenesis, oxidative stress, and cellular resilience. The second investigates how Urolithin A restored mitophagy and eliminated anxiety-like behavior in animal models. The third demonstrates how Urolithin B improved depression-like behavior by activating mitochondrial quality-control pathways through SLP2 and the PINK1/Parkin signaling system. While much of the evidence remains preclinical, the convergence across these independent research groups is striking. Rather than focusing on three different diseases, the episode explores one shared biological thread: mitochondrial quality control. If these findings continue to translate into humans, they could fundamentally reshape how we think about metabolism, aging, inflammation, resilience, and brain health. (Educational content only, not medical advice.) - Articles Discussed in Episode: The GLP-1–Mitochondria Axis in Metabolic Aging Urolithin A Abolishes High Anxiety and Rescues the Associated Mitochondria-Related Transcriptomic Signatures and Synaptic Function Urolithin B Ameliorates Depressive-Like Behavior and Hippocampal Neuronal Damage in Depressed Rats via Regulation of the SLP2/PINK1/Parkin Signaling Pathway - Key Quotes From Dr. Mike: "The real question isn't whether one of these compounds works — it's whether we're uncovering a broader mitochondria-metabolism-brain axis." "Mitochondrial dysfunction sits at the center of metabolic aging." "GLP-1 drugs may be touching the exact mitochondrial machinery that declines with age." "Urolithin A didn't simply reduce anxiety — it appeared to restore the mitochondrial quality control system underlying it." "Urolithin B improved behavior, protected hippocampal neurons, and reduced neuroinflammation." "Mitochondrial quality control may be one of the shared nodes connecting metabolism, aging, inflammation, and the brain." "The mitochondrion is beginning to look less like a power plant and more like a resilience hub." - Key Points ⚡ Three newly published studies explored metabolic aging, anxiety, and depression—but all converged on mitochondrial biology as a shared mechanism. ⚡ The episode introduces the emerging concept of the mitochondria-metabolism-brain axis. ⚡ A new Aging Cell review proposes that mitochondrial dysfunction sits at the center of metabolic aging. ⚡ Age-related declines in NAD, sirtuins, PGC-1α, mitochondrial biogenesis, and mitophagy may collectively drive metabolic decline. ⚡ GLP-1 receptor agonists may influence mitochondrial function through AMPK, PGC-1α, NRF2, and mitophagy pathways. ⚡ Despite compelling mechanisms, direct mitochondrial benefits of GLP-1 drugs in humans remain an active hypothesis—not established fact. ⚡ Large clinical trials continue to demonstrate significant cardiovascular and metabolic benefits from GLP-1 therapies. ⚡ Neurons have extraordinarily high energy demands, making the brain especially vulnerable to mitochondrial dysfunction. ⚡ A new Biological Psychiatry study found that Urolithin A eliminated anxiety-like behavior in multiple rodent models. ⚡ Urolithin A restored mitochondrial quality control by improving mitophagy through the PINK1/Parkin pathway. ⚡ The anti-anxiety effects occurred without sedation and primarily benefited animals exhibiting high anxiety. ⚡ Urolithin A also restored neuronal connectivity, dendritic complexity, synaptic function, and Mitofusin-2 expression. ⚡ A second study found that Urolithin B significantly improved depression-like behavior in stressed rats. ⚡ Urolithin B reduced neuroinflammation, preserved hippocampal neurons, increased BDNF and serotonin, and lowered corticosterone. ⚡ Researchers identified SLP2 as a key upstream regulator driving PINK1/Parkin-mediated mitophagy. ⚡ Knocking down SLP2 largely eliminated Urolithin B's protective effects, strengthening the proposed mechanism. ⚡ All three papers independently converged on mitochondrial quality control and mitophagy as central biological processes. ⚡ The PINK1/Parkin pathway appeared repeatedly across metabolic aging, anxiety, and depression research. ⚡ Mitochondrial quality control may represent a shared biological node linking seemingly unrelated chronic diseases. ⚡ The most important takeaway isn't any single molecule—it's the growing evidence that mitochondrial resilience may influence multiple organ systems simultaneously. - Episode timeline 00:00 – One Question Connects Three Diseases Could metabolic aging, anxiety, and depression all share one biological mechanism? 02:30 – The GLP-1 Mitochondrial Axis Aging Cell review Mitochondrial dysfunction and metabolic aging NAD, sirtuins, PGC-1α, mitophagy Human vs. animal evidence 16:40 – Why the Brain Depends on Healthy Mitochondria Neuronal energy demands Why mitochondrial dysfunction disproportionately affects the brain 18:40 – Urolithin A and Anxiety Biological Psychiatry study Anxiety models Mitophagy restoration PINK1/Parkin pathway Mitofusin-2 27:00 – Urolithin B and Depression Brain Research Bulletin study SLP2 signaling PINK1/Parkin activation Hippocampal neuroprotection Behavioral improvements 36:30 – The Bigger Picture How all three studies converge The mitochondria-metabolism-brain axis Why mitochondrial quality control may become one of the defining concepts in longevity science 41:30 – Final Takeaways What we know What remains speculative Why this emerging field deserves close attention - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn BioLight Labs: Website Instagram BioLight: Website Instagram YouTube Facebook